Medpace Holdings, Inc. (MEDP): A Bull Case Theory
We came across a bullish thesis on Medpace Holdings, Inc. (MEDP) on Substack by Compound & Fire. In this article, we will summarize the bulls’ thesis on MEDP. Medpace Holdings, Inc.
Medpace Holdings Inc. (MEDP)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 577,688 | $176,015,757 | +5% | 0.27% |
| 2. | AQR Capital Management Cliff Asness | 539,547 | $158,470,350 | +13% | 0.16% |
| 3. | Giverny Capital Francois Rochon | 251,937 | $76,762,685 | +8% | 2.83% |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 244,500 | $74,496,705 | +16% | 0.17% |
| 5. | D E Shaw D. E. Shaw | 214,178 | $65,257,894 | +21% | 0.06% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $326.11 | 2 | $652.22 | 13,343 | 2025-02-27 | Filing | |
| $154.59 | 57,426 | $8,877,485.34 | 6,483,019 | 2022-09-22 | Filing | |
| $154.59 | 57,426 | $8,877,485.34 | 6,483,019 | 2022-09-22 | Filing | |
| $161.63 | 94,119 | $15,212,453.97 | 6,425,593 | 2022-09-21 | Filing | |
| $155.14 | 94,119 | $14,601,621.66 | 6,331,474 | 2022-09-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $301.82 | 1,712 | $516,715.84 | 2,998 | 2025-04-24 | Filing | |
| $345.59 | 4,003 | $1,383,396.77 | 26,032 | 2025-02-24 | Filing | |
| $390.73 | 3,774 | $1,474,615.02 | 520 | 2024-08-23 | Filing | |
| $390.73 | 4,353 | $1,700,847.69 | 520 | 2024-08-22 | Filing | |
| $401.20 | 7,681 | $3,081,617.20 | 7,500 | 2024-06-05 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 859 | $269,606 | 0.03% | |
| 2. | 655 | $205,578 | 0.22% | |
| 3. | 271 | $85,056 | 0.01% |
News See All
Medpace Holdings, Inc. (NASDAQ:MEDP) Q1 2025 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the Medpace Holdings, Inc. First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.
What Makes Medpace Holdings (MEDP) a Better Investment?
Giverny Capital Asset Management, LLC, an investment management company, recently published its first-quarter 2025 investor letter. A copy of the letter can be downloaded here.
What Makes Medpace Holdings (MEDP) an Investment Bet?
Investment management company Vulcan Value Partners recently released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Medpace Holdings, Inc. (MEDP): A Bull Case Theory
We came across a bullish thesis on Medpace Holdings, Inc. (MEDP) on Substack by Tired Salary Bear. In this article, we will summarize the bulls’ thesis on MEDP. Medpace Holdings, Inc.
Here’s How LVS Advisory Embraced Change in Medpace Holdings (MEDP) Investments
LVS Advisory, a New York City-based full-service investment firm, recently released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
12 Best Diagnostics Stocks to Invest In Right Now
According to a report by Mordor Intelligence, the clinical diagnostics market has a size of $88.79 billion as of 2025.
Here are the Reasons to Invest in Medpace Holdings (MEDP)
Madison Investments, an investment advisor, released its “Madison Small Cap Fund” fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Medpace Holdings, Inc. (MEDP): A Bull Case Theory
We came across a bullish thesis on Medpace Holdings, Inc. (MEDP) on Substack by Long-Term Pick. In this article, we will summarize the bulls’ thesis on MEDP. Medpace Holdings, Inc.
Medpace Holdings, Inc. (NASDAQ:MEDP) Q4 2024 Earnings Call Transcript
Operator: And good day, ladies and gentlemen, and welcome to the Medpace Holdings, Inc. Fourth Quarter and Full Year 2024 Earnings Conference Call.
Billionaire Hedge Funds
